Skip to content

Effectiveness of Profhilo on Acne scar.

Evaluating the effectiveness of subcision in combination with Profhilo in comparison with subcision filler injection alone on acne scar among patients treated at the dermatology clinic

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201210049671N1
Enrollment
12
Registered
2021-04-08
Start date
2021-03-04
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic acne scar. Acne

Interventions

Intervention 1: Intervention group: The randomized site of the face will undergone subcision and intradermal Profhilo filler injection, and will be repeated after 1 month. Intervention 2: Control grou

Sponsors

Tehran University of Medical Sciences
Lead Sponsor
IBSA Farmaceutici
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Adults aging between 18-40 Presence of bilateral atrophic acne scar Being a potential candida for subcision procedure Informed consent and patient agreement for participation No previous procedure in last 3 months

Exclusion criteria

Exclusion criteria: Previous filler injection in the intervening site Coagulation disorder Autoimmune diseases Infection at the site Allergy to hyalouronic acid products Pregnancy and breast feeding Isotretinoin consumption during last 6 months

Design outcomes

Primary

MeasureTime frame
Acne scar depth. Timepoint: At baseline and after 3 months. Method of measurement: Skin ultrasonography.;Total acne scar severity. Timepoint: At the base of study and after 3 months. Method of measurement: Photographic image analysis by dermatologist.;Acne severity based on self-assessment scoring. Timepoint: At the base of study and then after 3 months. Method of measurement: Visual analogue scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKamran Balighi

Tehran University of Medical Sciences

kamran.balighi@yahoo.com+98 21 5563 0223

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026